Mrs. Gail Renee Johnson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2465 83rd Ave, Osceola, WI 54020 Phone: 715-755-2483 |
Kasandra Marie Lassonde, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2650 65th Ave, Osceola, WI 54020 Phone: 715-294-1100 |
Kayla Tornio Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2650 65th Ave, Osceola, WI 54020 Phone: 715-294-1100 |
Megan Michelle Jones, MS, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2650 65th Ave, Osceola, WI 54020 Phone: 715-294-1100 |
News Archive
The Associated Press: "A controversial decision by Arizona lawmakers to eliminate a health insurance program for poor children puts it at risk of losing billions of dollars in federal Medicaid funding under the historic health care bill approved by Congress. Arizona last week became the first state to eliminate its Children's Health Insurance Program, removing an estimated 38,000 kids from the rolls starting in June in a budget-cutting move by Gov. Jan Brewer and the Republican-led Legislature. ... Rep. Kyrsten Sinema, D-Phoenix, told Brewer and House Speaker Kirk Adams in separate letters that eliminating the state's KidsCare program on June 15 would violate a 'maintenance of effort' requirement of the Senate health care overhaul bill approved by Congress" (Davenport, 3/22).
Officials for Indiana-based WellPoint, the largest U.S. health insurer in terms of membership, on Tuesday announced that the company on Jan. 1, 2007, will begin to offer consumer-driven health plans to individuals and companies of all sizes, the Indianapolis Star reports.
Sigma-Aldrich Corporation is pleased to announce that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers nine new stable isotope-labeled internal standards of 2C amines including deuterium and 13C labeling.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased coronary tissue and guide therapeutic interventions, today announced that its next-generation LipiScan IVUS Coronary Imaging System will be featured at EuroPCR 2010, an international educational conference focused on introducing the latest techniques, updates and breakthrough science to the interventional cardiology community.
› Verified 1 days ago